On August 30, 2018 Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, reported that Shalini Sharp, the Company’s Chief Financial Officer, will present at the following upcoming investor conferences (Press release, Ultragenyx Pharmaceutical, AUG 30, 2018, View Source [SID1234529336]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Baird Global Healthcare Conference on Thursday, September 6, 2018 at 10:15am ET in New York.
Morgan Stanley Global Healthcare Conference on Thursday, September 13, 2018 at 4:40pm ET in New York.
The live and archived webcast of the Company presentations will be accessible from the Company’s website at View Source The replay of the webcast will be available for 90 days.